Therapy in RCDII: Rationale for Combination Strategies?

Author(s):
Nijeboer, P.; Malamut, G.; Bouma, G.; Cerf-Bensussan, N.; Koning, F. (0000-0002-4007-5715); Bergen, J. van; Cellier, C.; Mulder, C.J.J.
Published
2015
Publication type
Article / Letter to editor
Refractory coeliac disease type IICoeliac diseaseEnteropathy-associated T-cell lymphomaTofacitinib
Date issued
2015-12-31
Language
English
Is part of
Digestive Diseases (2015), Vol. 33, no. 2, p. 227-230
hdl
1887/104599
doi
10.1159/000381076